Erum Anwar Khan: NICE NG126 2026 Update on Anti-D in Early Pregnancy
Erum Anwar Khan, National Maternity Improvement Advisor at NHS England, shared a post on LinkedIn:
“NICE NG126 Update (2026): Ectopic pregnancy and miscarriage: diagnosis and initial management.
One of the most significant updates in the latest NICE NG126 guideline is the change to Anti-D immunoglobulin use in RhD-negative patients.
Anti-D is no longer recommended before 12 weeks’ gestation (up to 11+6 weeks) for:
- Ectopic pregnancy
- Miscarriage
- Threatened miscarriage
At 12+0 to 12+6 weeks, Anti-D (minimum 250 IU) should be offered for medical or surgical management of miscarriage or ectopic pregnancy, and considered for threatened miscarriage with heavy or recurrent bleeding.
Where there is discrepancy between length of gestation as measured from ultrasound and that calculated from last menstrual period, the findings from ultrasound should be used to guide management.
Kleihauer testing is not recommended for quantifying feto-maternal haemorrhage in this setting. This is not a new update.
This represents a notable shift away from historical practice, where Anti-D was frequently administered following early pregnancy loss regardless of gestation.
The update reflects the growing evidence that the risk of RhD sensitisation before 12 weeks is extremely low and that routine prophylaxis in this group offers limited benefit.
For EPAUs, emergency gynaecology services and primary care, this change will likely reduce unnecessary administration of a blood-derived product, simplify care pathways and support more evidence-based use of Anti-D.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 16, 2026, 19:56Dina Ibrahem: Poor ICM vs. Poor TE
-
Oct 16, 2026, 19:47Sean Lauber: NIPT and Amniocentesis after PGT-A Reveal Few Abnormalities
-
Oct 16, 2026, 19:42Devyanshi Dixit: C-Section vs. Vaginal Birth – 2 Birth Paths, 2 Very Different Recoveries
-
Oct 16, 2026, 19:32Pawel Kordowitzki: Maternal Vitamin D Homeostasis, Pregnancy Outcomes and Offspring Health
-
Oct 16, 2026, 19:13Shizuko Takahashi: Our Study on Women’s Experiences of Assisted Reproductive Care in China Has Been Accepted by RBMO
-
Oct 16, 2026, 19:09ESHRE Announces ECRES-GESEA Reproductive Surgery Training and Certification in Slovenia
-
Oct 16, 2026, 18:20Kabita KB: What Happens if PLCZ1 Is Defective?
-
Oct 16, 2026, 18:12Partha Sarathi Das: From Reproductive Lifespan to Reproductive Healthspan
-
Oct 16, 2026, 18:05Joyce Harper: It Was a Pleasure to Give 2 Talks Celebrating World Menopause Day
